Entry Detail



General Information

Database ID:exR0080648
RNA Name:RPS19
RNA Type:mRNA
Chromosome:chr19
Starnd:+
Coordinate:
Start Site(bp):41860255End Site(bp):41872925
External Links:ENSG00000105372



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ACADM
chr1
75724347
75787575
+
ALDOA
chr16
30064164
30070457
+
ACTG1
chr17
81509971
81523847
-
ABCC5
chr3
183919934
184017939
-
AL022238.4
chr22
40346529
40410054
+
AC092143.1
chr16
89919165
89936092
+
AHRR
chr5
271670
438291
+
ADD1
chr4
2843857
2930076
+
ALDH7A1
chr5
126531200
126595362
-
AL136295.4
chr14
24180395
24190416
-
AC011511.1
chr19
10305427
10316009
-
ADA
chr20
44619522
44652233
-
AIFM1
chrX
130129362
130165887
-
AC087289.3
chr17
75898645
75930129
-
ACAD9
chr3
128879596
128916067
+
AL358113.1
chr9
69035747
69255187
+
AKNA
chr9
114334156
114394405
-
AC005258.1
chr19
2269525
2341172
+
AK1
chr9
127866486
127877675
-
ABHD8
chr19
17292131
17310236
-
AC010422.3
chr19
12643831
12648397
-
AKT2
chr19
40230317
40285536
-
AGFG1
chr2
227472152
227561214
+
ACSS2
chr20
34872146
34927962
+
AC026464.4
chr16
69299682
69322700
+
ACOX1
chr17
75941507
75979177
-
AGFG2
chr7
100539203
100568220
+
ADH5
chr4
99070978
99088801
-
AC120057.2
chr17
7240427
7244635
-
AC048338.1
chr12
122207779
122266423
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-130b-5p
chr22
21653316
21653336
+
hsa-miR-4284
chr7
73711327
73711344
+
hsa-miR-6797-3p
chr19
41869675
41869696
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004687.1
chr17
58330884
58332508
-
AC008033.3
chr12
68426331
68427737
-
AC010327.5
chr19
55216660
55221616
+
AC016876.2
chr17
7581964
7584086
-
AC026304.1
chr3
143000907
143001467
-
AC067930.1
chr8
143579636
143580670
+
AC068338.2
chr15
75368155
75369584
+
AC074135.1
chr19
23075201
23100361
+
AC090204.1
chr8
32927913
33045445
+
AC105036.3
chr15
75527150
75601205
-
AC132217.1
chr11
2129121
2129964
-
AC133540.1
chr16
85489813
85490831
+
AC135048.1
chr16
30948386
30956511
+
AC148477.2
chr12
132277349
132280900
+
AD000090.1
chr19
35557956
35581954
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA